Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
6
TGA:6
Drug Approvals
OXLUMO lumasiran (as sodium) 94.5 mg/0.5 mL injection vial. (421050)
- Product Name
- OXLUMO lumasiran (as sodium) 94.5 mg/0.5 mL injection vial.
- Approval Date
- Jun 24, 2024
TGA
AMVUTTRA, vutrisiran (as sodium) 25 mg / 0.5 mL solution for injection pre-filled syringe (422290)
- Product Name
- AMVUTTRA, vutrisiran (as sodium) 25 mg / 0.5 mL solution for injection pre-filled syringe
- Approval Date
- Jun 21, 2024
TGA
GIVLAARI givosiran 189 mg/1mL solution for injection vial (401153)
- Product Name
- GIVLAARI givosiran 189 mg/1mL solution for injection vial
- Approval Date
- Nov 28, 2023
TGA
ONPATTRO patisiran 10 mg/5 mL concentrated injection for infusion vial (380813)
- Product Name
- ONPATTRO patisiran 10 mg/5 mL concentrated injection for infusion vial
- Approval Date
- Nov 21, 2022
TGA
KIMMTRAK tebentafusp 0.1 mg/0.5 mL concentrated solution for infusion vial (375296)
- Product Name
- KIMMTRAK tebentafusp 0.1 mg/0.5 mL concentrated solution for infusion vial
- Approval Date
- Jun 3, 2022
TGA
LIBTAYO cemiplimab 350 mg concentrate for solution for infusion (320609)
- Product Name
- LIBTAYO cemiplimab 350 mg concentrate for solution for infusion
- Approval Date
- Jul 17, 2020
TGA
Clinical Trials
No trials found
News
No news found